These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 5483969)

  • 1. Exercise induced increase in split products of fibrinogen.
    Ferguson EW; Nanninga LB
    Thromb Diath Haemorrh; 1970 Oct; 24(1):302-3. PubMed ID: 5483969
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen-fibrin degradation products and fibrinolysis following exercise in humans.
    Karp JE; Bell WR
    Am J Physiol; 1974 Nov; 227(5):1212-5. PubMed ID: 4440763
    [No Abstract]   [Full Text] [Related]  

  • 3. Urokinase-induced fibrinolysis of 125-I-fibrin. Conditions for first-order activation kinetics, density-gradient separation of split products, and a microassay.
    Ball AP; Day ED
    Thromb Diath Haemorrh; 1970 Dec; 24(3):463-74. PubMed ID: 5503943
    [No Abstract]   [Full Text] [Related]  

  • 4. Exercise-induced fibrinolysis--fact or fiction?
    Marsh NA; Gaffney PJ
    Thromb Haemost; 1982 Oct; 48(2):201-3. PubMed ID: 6217583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 6. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis at rest and after exercise in hepatic cirrhosis.
    Das PC; Cash JD
    Br J Haematol; 1969 Nov; 17(5):431-43. PubMed ID: 5346820
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.
    Collet JP; Nagaswami C; Farrell DH; Montalescot G; Weisel JW
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):382-6. PubMed ID: 14656741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of tryptic hydrolysates of fibrin and fibrinogen on polymerization of monomer fibrin].
    Gavrish IN
    Ukr Biokhim Zh; 1970; 42(6):736-42. PubMed ID: 5513585
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of urinary protein C inhibitor to fibrin(ogen) and its binding mechanism.
    Hayashi S; Yamada K
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):153-8. PubMed ID: 8384496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coagulation and fibrinolysis systems and atherosclerosis.
    Tanaka K; Sueishi K
    Lab Invest; 1993 Jul; 69(1):5-18. PubMed ID: 8331898
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen, fibrin and crosslinking in aging arterial thrombi.
    McBane RD; Ford MA; Karnicki K; Stewart M; Owen WG
    Thromb Haemost; 2000 Jul; 84(1):83-7. PubMed ID: 10928475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Description of new fibrinolytic enzyme, isolated from the haemolymph of Rhodnius prolixus Stal (Heteroptera Reduviidae).
    Ben Hamouda MH; Soria J; Soria C
    Arch Inst Pasteur Tunis; 1982; 59(2-3):251-68. PubMed ID: 6762857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma levels of crosslinked fibrinogen gamma-chain dimer indicate cancer-related fibrin deposition and fibrinolysis.
    Gerner C; Steinkellner W; Holzmann K; Gsur A; Grimm R; Ensinger C; Obrist P; Sauermann G
    Thromb Haemost; 2001 Mar; 85(3):494-501. PubMed ID: 11307821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin degradation products. A review of structures found in vitro and in vivo.
    Gaffney PJ
    Ann N Y Acad Sci; 2001; 936():594-610. PubMed ID: 11460518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two families of synthetic peptides that enhance fibrin turbidity and delay fibrinolysis by different mechanisms.
    Pandi L; Kollman JM; Lopez-Lira F; Burrows JM; Riley M; Doolittle RF
    Biochemistry; 2009 Aug; 48(30):7201-8. PubMed ID: 19588915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.